Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
Open Access
- 9 July 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Gastroenterology
- Vol. 10 (1), 78
- https://doi.org/10.1186/1471-230x-10-78
Abstract
Background There is no clear consensus on the better therapy [radiofrequency ablation (RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for surgical treatments. This study is a meta-analysis of the available evidence. Methods Systematic review and meta-analysis of trials comparing RFA with HR for small HCC published from 1997 to 2009 in PubMed and Medline. Pooled odds ratios (OR) with 95% confidence intervals (95% CI) were calculated using either the fixed effects model or random effects model. Results One randomized controlled trial, and 9 nonrandomized controlled trials studies were included in this analysis. These studies included a total of 1411 patients: 744 treated with RFA and 667 treated with HR. The overall survival was significantly higher in patients treated with HR than in those treated with RFA at 3 years (OR: 0.56, 95% CI: 0.44-0.71), and at 5 year (OR: 0.60, 95% CI: 0.36-1.01). RFA has a higher rates of local intrahepatic recurrence compared to HR (OR: 4.50, 95% CI: 2.45-8.27). In the HR group the 1, 3, and 5 years disease -free survival rates were significantly better than in the HR-treated patients (respectively: OR: 0.54, 95% CI: 0.35-0.84; OR: 0.44, 95% CI: 0.28-0.68; OR: 0.64, 95% CI: 0.42-0.99). The postoperative morbidity was higher with HR (OR: 0.29, 95% CI: 0.13-0.65), but no significant differences were found concerning mortality. For tumors ≤ 3 cm HR did not differ significantly from RFA for survival, as reported in three NRCTs . Conclusions HR was superior to RFA in the treatment of patients with small HCC eligible for surgical treatments, particularly for tumors > 3 cm. However, the findings have to be carefully interpreted due to the lower level of evidence.Keywords
This publication has 33 references indexed in Scilit:
- Surgical Resection Versus Laparoscopic Radiofrequency Ablation in Patients With Hepatocellular Carcinoma and Child-Pugh Class A Liver CirrhosisAnnals of Surgical Oncology, 2009
- Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinomaBMC Gastroenterology, 2009
- Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteriaJournal of Hepato-Biliary-Pancreatic Surgery, 2009
- Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: Risk factors and patternsThe Esophagus, 2008
- Single hepatocellular carcinoma ranging from 3 to 5cm: radiofrequency ablation or resection?HPB, 2007
- Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: Long‐term outcomesHPB, 2005
- Long-term outcomes for patients with solitary hepatocellular carcinoma treated by laparoscopic microwave coagulationCancer, 2005
- Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysisJournal of Gastrointestinal Surgery, 2005
- Factors correlated with portal venous invasion by hepatocellular carcinoma: Univariate and multivariate analyses of 232 resected cases without preoperative treatmentsCancer, 1996
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990